Search

Your search keyword '"Halle, M.K."' showing total 7 results
Start Over Author "Halle, M.K."
7 results on '"Halle, M.K."'

3. Endometrial Carcinoma Recurrence Score (ECARS) validates to identify aggressive disease and associates with markers of epithelial–mesenchymal transition and PI3K alterations

Author

Wik, E., Trovik, J., Kusonmano, K., Birkeland, E., Raeder, M.B., Pashtan, I., Hoivik, E.A., Krakstad, C., Werner, H.M.J., Holst, F., Mjøs, S., Halle, M.K., Mannelqvist, M., Mauland, K.K., Oyan, A.M., Stefansson, I.M., Petersen, K., Simon, R., Cherniack, A.D., Meyerson, M., Kalland, K.H., Akslen, L.A., and Salvesen, H.B.

Published
2014
Full Text
View/download PDF

4. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA

Author

Earp, M.A., Kelemen, L.E., Magliocco, A.M., Swenerton, K.D., Chenevix-Trench, G., Lu, Y., Hein, A., Ekici, A.B., Beckmann, M.W., Fasching, P.A., Lambrechts, D., Despierre, E., Vergote, I., Lambrechts, S., Doherty, J.A., Rossing, M.A., Chang-Claude, J., Rudolph, A., Friel, G., Moysich, K.B., Odunsi, K., Sucheston-Campbell, L., Lurie, G., Goodman, M.T., Carney, M.E., Thompson, P.J., Runnebaum, I.B., Durst, M., Hillemanns, P., Dork, T., Antonenkova, N., Bogdanova, N., Leminen, A., Nevanlinna, H., Pelttari, L.M., Butzow, R., Bunker, C.H., Modugno, F., Edwards, R.P., Ness, R.B., Bois, A. du, Heitz, F., Schwaab, I., Harter, P., Karlan, B.Y., Walsh, C., Lester, J., Jensen, A., Kjaer, S.K., Hogdall, C.K., Hogdall, E., Lundvall, L., Sellers, T.A., Fridley, B.L., Goode, E.L., Cunningham, J.M., Vierkant, R.A., Giles, G.G., Baglietto, L., Severi, G., Southey, M.C., Liang, D., Wu, X., Lu, K., Hildebrandt, M.A.T., Levine, D.A., Bisogna, M., Schildkraut, J.M., Iversen, E.S., Weber, R.P., Berchuck, A., Cramer, D.W, Terry, K.L., Poole, E.M., Tworoger, S.S., Bandera, E.V., Chandran, U., Orlow, I., Olson, S.H., Wik, E., Salvesen, H.B., Bjorge, L., Halle, M.K., Altena, A.M. van, Aben, K.K.H., Kiemeney, B., Massuger, L.F.A.G., Pejovic, T., Bean, Y.T., Cybulski, C., Gronwald, J., Lubinski, J., Wentzensen, N., Brinton, L.A., Lissowska, J., Garcia-Closas, M., Dicks, E., et al., Earp, M.A., Kelemen, L.E., Magliocco, A.M., Swenerton, K.D., Chenevix-Trench, G., Lu, Y., Hein, A., Ekici, A.B., Beckmann, M.W., Fasching, P.A., Lambrechts, D., Despierre, E., Vergote, I., Lambrechts, S., Doherty, J.A., Rossing, M.A., Chang-Claude, J., Rudolph, A., Friel, G., Moysich, K.B., Odunsi, K., Sucheston-Campbell, L., Lurie, G., Goodman, M.T., Carney, M.E., Thompson, P.J., Runnebaum, I.B., Durst, M., Hillemanns, P., Dork, T., Antonenkova, N., Bogdanova, N., Leminen, A., Nevanlinna, H., Pelttari, L.M., Butzow, R., Bunker, C.H., Modugno, F., Edwards, R.P., Ness, R.B., Bois, A. du, Heitz, F., Schwaab, I., Harter, P., Karlan, B.Y., Walsh, C., Lester, J., Jensen, A., Kjaer, S.K., Hogdall, C.K., Hogdall, E., Lundvall, L., Sellers, T.A., Fridley, B.L., Goode, E.L., Cunningham, J.M., Vierkant, R.A., Giles, G.G., Baglietto, L., Severi, G., Southey, M.C., Liang, D., Wu, X., Lu, K., Hildebrandt, M.A.T., Levine, D.A., Bisogna, M., Schildkraut, J.M., Iversen, E.S., Weber, R.P., Berchuck, A., Cramer, D.W, Terry, K.L., Poole, E.M., Tworoger, S.S., Bandera, E.V., Chandran, U., Orlow, I., Olson, S.H., Wik, E., Salvesen, H.B., Bjorge, L., Halle, M.K., Altena, A.M. van, Aben, K.K.H., Kiemeney, B., Massuger, L.F.A.G., Pejovic, T., Bean, Y.T., Cybulski, C., Gronwald, J., Lubinski, J., Wentzensen, N., Brinton, L.A., Lissowska, J., Garcia-Closas, M., Dicks, E., and et al.

Abstract

Contains fulltext : 138102.pdf (publisher's version ) (Closed access), Epithelial ovarian cancer (EOC) is a heterogeneous cancer with both genetic and environmental risk factors. Variants influencing the risk of developing the less-common EOC subtypes have not been fully investigated. We performed a genome-wide association study (GWAS) of EOC according to subtype by pooling genomic DNA from 545 cases and 398 controls of European descent, and testing for allelic associations. We evaluated for replication 188 variants from the GWAS [56 variants for mucinous, 55 for endometrioid and clear cell, 53 for low-malignant potential (LMP) serous, and 24 for invasive serous EOC], selected using pre-defined criteria. Genotypes from 13,188 cases and 23,164 controls of European descent were used to perform unconditional logistic regression under the log-additive genetic model; odds ratios (OR) and 95 % confidence intervals are reported. Nine variants tagging six loci were associated with subtype-specific EOC risk at P < 0.05, and had an OR that agreed in direction of effect with the GWAS results. Several of these variants are in or near genes with a biological rationale for conferring EOC risk, including ZFP36L1 and RAD51B for mucinous EOC (rs17106154, OR = 1.17, P = 0.029, n = 1,483 cases), GRB10 for endometrioid and clear cell EOC (rs2190503, P = 0.014, n = 2,903 cases), and C22orf26/BPIL2 for LMP serous EOC (rs9609538, OR = 0.86, P = 0.0043, n = 892 cases). In analyses that included the 75 GWAS samples, the association between rs9609538 (OR = 0.84, P = 0.0007) and LMP serous EOC risk remained statistically significant at P < 0.0012 adjusted for multiple testing. Replication in additional samples will be important to verify these results for the less-common EOC subtypes.

Published
2014

5. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer

Author

Shen, H., Fridley, B.L., Song, H., Lawrenson, K., Cunningham, J.M., Ramus, S.J., Cicek, M.S., Tyrer, J., Stram, D., Larson, M.C., Kobel, M., Ziogas, A., Zheng, W., Yang, H.P., Wu, A.H., Wozniak, E.L., Ling Woo, Y., Winterhoff, B., Wik, E., Whittemore, A.S., Wentzensen, N., Palmieri Weber, R., Vitonis, A.F., Vincent, D., Vierkant, R.A., Vergote, I., Berg, D.P.G. van den, Altena, A.M. van, Tworoger, S.S., Thompson, P.J., Tessier, D.C., Terry, K.L., Teo, S.H., Templeman, C., Stram, D.O., Southey, M.C., Sieh, W., Siddiqui, N., Shvetsov, Y.B., Shu, X.O., Shridhar, V., Wang-Gohrke, S., Severi, G., Schwaab, I., Salvesen, H.B., Rzepecka, I.K., Runnebaum, I.B., Rossing, M.A., Rodriguez-Rodriguez, L., Risch, H.A., Renner, S.P., Poole, E.M., Pike, M.C., Phelan, C.M., Pelttari, L.M., Pejovic, T., Paul, J., Orlow, I., Zawiah Omar, S., Olson, S.H., Odunsi, K., Nickels, S., Nevanlinna, H., Ness, R.B., Narod, S.A., Nakanishi, T., Moysich, K.B., Monteiro, A.N., Moes-Sosnowska, J., Modugno, F., Menon, U., McLaughlin, J.R., McGuire, V., Matsuo, K., Mat Adenan, N.A., Massuger, L.F.A.G., Lurie, G., Lundvall, L., Lubinski, J., Lissowska, J., Levine, D.A., Leminen, A., Lee, A.W., Le, N.D., Lambrechts, S., Lambrechts, D., Kupryjanczyk, J., Krakstad, C., Konecny, G.E., Kruger Kjaer, S., Kiemeney, L.A.L.M., Kelemen, L.E., Keeney, G.L., Karlan, B.Y., Karevan, R., Kalli, K.R., Kajiyama, H., Ji, B.T., Jensen, A., Jakubowska, A., Iversen, E., Hosono, S., Hogdall, C.K., Hogdall, E., Hoatlin, M., Hillemans, P., Heitz, F., Hein, R., Harter, P., Halle, M.K., Hall, P., Gronwald, J., Gore, M., Goodman, M.T., Giles, G.G., Gentry-Maharaj, A., Garcia-Closas, M., Flanagan, J.M., Fasching, P.A., Ekici, A.B., Edwards, R., Eccles, D., Easton, D.F., Durst, M., Bois, A. du, Dork, T., Doherty, J.A., Despierre, E., Dansonka-Mieszkowska, A., Cybulski, C., Cramer, D.W, Cook, L.S., Chen, X., Charbonneau, B., Chang-Claude, J., Campbell, I., Butzow, R., Bunker, C.H., Brueggmann, D., Brown, R., Brooks-Wilson, A., Brinton, L.A., Bogdanova, N., Block, M.S., Benjamin, E., Beesley, J., Beckmann, M.W., Bandera, E.V., Baglietto, L., Bacot, F., Armasu, S.M., Antonenkova, N., Anton-Culver, H., Aben, K.K.H., Liang, D., et al., Shen, H., Fridley, B.L., Song, H., Lawrenson, K., Cunningham, J.M., Ramus, S.J., Cicek, M.S., Tyrer, J., Stram, D., Larson, M.C., Kobel, M., Ziogas, A., Zheng, W., Yang, H.P., Wu, A.H., Wozniak, E.L., Ling Woo, Y., Winterhoff, B., Wik, E., Whittemore, A.S., Wentzensen, N., Palmieri Weber, R., Vitonis, A.F., Vincent, D., Vierkant, R.A., Vergote, I., Berg, D.P.G. van den, Altena, A.M. van, Tworoger, S.S., Thompson, P.J., Tessier, D.C., Terry, K.L., Teo, S.H., Templeman, C., Stram, D.O., Southey, M.C., Sieh, W., Siddiqui, N., Shvetsov, Y.B., Shu, X.O., Shridhar, V., Wang-Gohrke, S., Severi, G., Schwaab, I., Salvesen, H.B., Rzepecka, I.K., Runnebaum, I.B., Rossing, M.A., Rodriguez-Rodriguez, L., Risch, H.A., Renner, S.P., Poole, E.M., Pike, M.C., Phelan, C.M., Pelttari, L.M., Pejovic, T., Paul, J., Orlow, I., Zawiah Omar, S., Olson, S.H., Odunsi, K., Nickels, S., Nevanlinna, H., Ness, R.B., Narod, S.A., Nakanishi, T., Moysich, K.B., Monteiro, A.N., Moes-Sosnowska, J., Modugno, F., Menon, U., McLaughlin, J.R., McGuire, V., Matsuo, K., Mat Adenan, N.A., Massuger, L.F.A.G., Lurie, G., Lundvall, L., Lubinski, J., Lissowska, J., Levine, D.A., Leminen, A., Lee, A.W., Le, N.D., Lambrechts, S., Lambrechts, D., Kupryjanczyk, J., Krakstad, C., Konecny, G.E., Kruger Kjaer, S., Kiemeney, L.A.L.M., Kelemen, L.E., Keeney, G.L., Karlan, B.Y., Karevan, R., Kalli, K.R., Kajiyama, H., Ji, B.T., Jensen, A., Jakubowska, A., Iversen, E., Hosono, S., Hogdall, C.K., Hogdall, E., Hoatlin, M., Hillemans, P., Heitz, F., Hein, R., Harter, P., Halle, M.K., Hall, P., Gronwald, J., Gore, M., Goodman, M.T., Giles, G.G., Gentry-Maharaj, A., Garcia-Closas, M., Flanagan, J.M., Fasching, P.A., Ekici, A.B., Edwards, R., Eccles, D., Easton, D.F., Durst, M., Bois, A. du, Dork, T., Doherty, J.A., Despierre, E., Dansonka-Mieszkowska, A., Cybulski, C., Cramer, D.W, Cook, L.S., Chen, X., Charbonneau, B., Chang-Claude, J., Campbell, I., Butzow, R., Bunker, C.H., Brueggmann, D., Brown, R., Brooks-Wilson, A., Brinton, L.A., Bogdanova, N., Block, M.S., Benjamin, E., Beesley, J., Beckmann, M.W., Bandera, E.V., Baglietto, L., Bacot, F., Armasu, S.M., Antonenkova, N., Anton-Culver, H., Aben, K.K.H., Liang, D., and et al.

Abstract

Contains fulltext : 118378.pdf (publisher's version ) (Open Access), HNF1B is overexpressed in clear cell epithelial ovarian cancer, and we observed epigenetic silencing in serous epithelial ovarian cancer, leading us to hypothesize that variation in this gene differentially associates with epithelial ovarian cancer risk according to histological subtype. Here we comprehensively map variation in HNF1B with respect to epithelial ovarian cancer risk and analyse DNA methylation and expression profiles across histological subtypes. Different single-nucleotide polymorphisms associate with invasive serous (rs7405776 odds ratio (OR)=1.13, P=3.1 x 10(-10)) and clear cell (rs11651755 OR=0.77, P=1.6 x 10(-8)) epithelial ovarian cancer. Risk alleles for the serous subtype associate with higher HNF1B-promoter methylation in these tumours. Unmethylated, expressed HNF1B, primarily present in clear cell tumours, coincides with a CpG island methylator phenotype affecting numerous other promoters throughout the genome. Different variants in HNF1B associate with risk of serous and clear cell epithelial ovarian cancer; DNA methylation and expression patterns are also notably distinct between these subtypes. These findings underscore distinct mechanisms driving different epithelial ovarian cancer histological subtypes.

Published
2013

6. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31

Author

Permuth-Wey, J., Lawrenson, K., Shen, H.C., Velkova, A., Tyrer, J.P., Chen, Z., Lin, H.Y., Ann Chen, Y., Tsai, Y.Y., Qu, X., Ramus, S.J., Karevan, R., Lee, J. van der, Lee, N., Larson, M.C., Aben, K.K.H., Anton-Culver, H., Antonenkova, N., Antoniou, A.C., Armasu, S.M., Bacot, F., Baglietto, L., Bandera, E.V., Barnholtz-Sloan, J., Beckmann, M.W., Birrer, M.J., Bloom, G., Bogdanova, N., Brinton, L.A., Brooks-Wilson, A., Brown, R., Butzow, R., Cai, Q., Campbell, I., Chang-Claude, J., Chanock, S., Chenevix-Trench, G., Cheng, J.Q., Cicek, M.S., Coetzee, G.A., Cook, L.S., Couch, F.J., Cramer, D.W, Cunningham, J.M., Dansonka-Mieszkowska, A., Despierre, E., Doherty, J.A., Dork, T., Bois, A. du, Durst, M., Easton, D.F., Eccles, D., Edwards, R., Ekici, A.B., Fasching, P.A., Fenstermacher, D.A., Flanagan, J.M., Garcia-Closas, M., Gentry-Maharaj, A., Giles, G.G., Glasspool, R.M., Gonzalez-Bosquet, J., Goodman, M.T., Gore, M., Gorski, B., Gronwald, J., Hall, P., Halle, M.K., Harter, P., Heitz, F., Hillemanns, P., Hoatlin, M., Hogdall, C.K., Hogdall, E., Hosono, S., Jakubowska, A., Jensen, A., Jim, H., Kalli, K.R., Karlan, B.Y., Kaye, S.B., Kelemen, L.E., Kiemeney, L.A.L.M., Kikkawa, F., Konecny, G.E., Krakstad, C., Kruger Kjaer, S., Kupryjanczyk, J., Lambrechts, D., Lambrechts, S., Lancaster, J.M., Le, N.D., Leminen, A., Levine, D.A., Liang, D., Kiong Lim, B., Lin, J., Massuger, L.F.A.G., Altena, A.M. van, et al., Permuth-Wey, J., Lawrenson, K., Shen, H.C., Velkova, A., Tyrer, J.P., Chen, Z., Lin, H.Y., Ann Chen, Y., Tsai, Y.Y., Qu, X., Ramus, S.J., Karevan, R., Lee, J. van der, Lee, N., Larson, M.C., Aben, K.K.H., Anton-Culver, H., Antonenkova, N., Antoniou, A.C., Armasu, S.M., Bacot, F., Baglietto, L., Bandera, E.V., Barnholtz-Sloan, J., Beckmann, M.W., Birrer, M.J., Bloom, G., Bogdanova, N., Brinton, L.A., Brooks-Wilson, A., Brown, R., Butzow, R., Cai, Q., Campbell, I., Chang-Claude, J., Chanock, S., Chenevix-Trench, G., Cheng, J.Q., Cicek, M.S., Coetzee, G.A., Cook, L.S., Couch, F.J., Cramer, D.W, Cunningham, J.M., Dansonka-Mieszkowska, A., Despierre, E., Doherty, J.A., Dork, T., Bois, A. du, Durst, M., Easton, D.F., Eccles, D., Edwards, R., Ekici, A.B., Fasching, P.A., Fenstermacher, D.A., Flanagan, J.M., Garcia-Closas, M., Gentry-Maharaj, A., Giles, G.G., Glasspool, R.M., Gonzalez-Bosquet, J., Goodman, M.T., Gore, M., Gorski, B., Gronwald, J., Hall, P., Halle, M.K., Harter, P., Heitz, F., Hillemanns, P., Hoatlin, M., Hogdall, C.K., Hogdall, E., Hosono, S., Jakubowska, A., Jensen, A., Jim, H., Kalli, K.R., Karlan, B.Y., Kaye, S.B., Kelemen, L.E., Kiemeney, L.A.L.M., Kikkawa, F., Konecny, G.E., Krakstad, C., Kruger Kjaer, S., Kupryjanczyk, J., Lambrechts, D., Lambrechts, S., Lancaster, J.M., Le, N.D., Leminen, A., Levine, D.A., Liang, D., Kiong Lim, B., Lin, J., Massuger, L.F.A.G., Altena, A.M. van, and et al.

Abstract

Contains fulltext : 118576.pdf (publisher's version ) (Open Access), Epithelial ovarian cancer (EOC) has a heritable component that remains to be fully characterized. Most identified common susceptibility variants lie in non-protein-coding sequences. We hypothesized that variants in the 3' untranslated region at putative microRNA (miRNA)-binding sites represent functional targets that influence EOC susceptibility. Here, we evaluate the association between 767 miRNA-related single-nucleotide polymorphisms (miRSNPs) and EOC risk in 18,174 EOC cases and 26,134 controls from 43 studies genotyped through the Collaborative Oncological Gene-environment Study. We identify several miRSNPs associated with invasive serous EOC risk (odds ratio=1.12, P=10(-8)) mapping to an inversion polymorphism at 17q21.31. Additional genotyping of non-miRSNPs at 17q21.31 reveals stronger signals outside the inversion (P=10(-10)). Variation at 17q21.31 is associated with neurological diseases, and our collaboration is the first to report an association with EOC susceptibility. An integrated molecular analysis in this region provides evidence for ARHGAP27 and PLEKHM1 as candidate EOC susceptibility genes.

Published
2013

7. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer

Author

Pharoah, P.D., Tsai, Y.Y., Ramus, S.J., Phelan, C.M., Goode, E.L., Lawrenson, K., Buckley, M., Fridley, B.L., Tyrer, J.P., Shen, H., Weber, R., Karevan, R., Larson, M.C., Song, H., Tessier, D.C., Bacot, F., Vincent, D., Cunningham, J.M., Dennis, J., Dicks, E., Aben, K.K.H., Anton-Culver, H., Antonenkova, N., Armasu, S.M., Baglietto, L., Bandera, E.V., Beckmann, M.W., Birrer, M.J., Bloom, G., Bogdanova, N., Brenton, J.D., Brinton, L.A., Brooks-Wilson, A., Brown, R., Butzow, R., Campbell, I., Carney, M.E., Carvalho, R.S., Chang-Claude, J., Chen, Y.A., Chen, Z., Chow, W.H., Cicek, M.S., Coetzee, G., Cook, L.S., Cramer, D.W, Cybulski, C., Dansonka-Mieszkowska, A., Despierre, E., Doherty, J.A., Dork, T., Bois, A. du, Durst, M., Eccles, D., Edwards, R., Ekici, A.B., Fasching, P.A., Fenstermacher, D., Flanagan, J., Gao, Y.T., Garcia-Closas, M., Gentry-Maharaj, A., Giles, G., Gjyshi, A., Gore, M., Gronwald, J., Guo, Q., Halle, M.K., Harter, P., Hein, A., Heitz, F., Hillemanns, P., Hoatlin, M., Hogdall, E., Hogdall, C.K., Hosono, S., Jakubowska, A., Jensen, A., Kalli, K.R., Karlan, B.Y., Kelemen, L.E., Kiemeney, L.A.L.M., Kjaer, S.K., Konecny, G.E., Krakstad, C., Kupryjanczyk, J., Lambrechts, D., Lambrechts, S., Le, N.D., Lee, N., Lee, J. van der, Leminen, A., Lim, B.K., Lissowska, J., Lubinski, J., Lundvall, L., Lurie, G., Massuger, L.F.A.G., Altena, A.M. van, Pharoah, P.D., Tsai, Y.Y., Ramus, S.J., Phelan, C.M., Goode, E.L., Lawrenson, K., Buckley, M., Fridley, B.L., Tyrer, J.P., Shen, H., Weber, R., Karevan, R., Larson, M.C., Song, H., Tessier, D.C., Bacot, F., Vincent, D., Cunningham, J.M., Dennis, J., Dicks, E., Aben, K.K.H., Anton-Culver, H., Antonenkova, N., Armasu, S.M., Baglietto, L., Bandera, E.V., Beckmann, M.W., Birrer, M.J., Bloom, G., Bogdanova, N., Brenton, J.D., Brinton, L.A., Brooks-Wilson, A., Brown, R., Butzow, R., Campbell, I., Carney, M.E., Carvalho, R.S., Chang-Claude, J., Chen, Y.A., Chen, Z., Chow, W.H., Cicek, M.S., Coetzee, G., Cook, L.S., Cramer, D.W, Cybulski, C., Dansonka-Mieszkowska, A., Despierre, E., Doherty, J.A., Dork, T., Bois, A. du, Durst, M., Eccles, D., Edwards, R., Ekici, A.B., Fasching, P.A., Fenstermacher, D., Flanagan, J., Gao, Y.T., Garcia-Closas, M., Gentry-Maharaj, A., Giles, G., Gjyshi, A., Gore, M., Gronwald, J., Guo, Q., Halle, M.K., Harter, P., Hein, A., Heitz, F., Hillemanns, P., Hoatlin, M., Hogdall, E., Hogdall, C.K., Hosono, S., Jakubowska, A., Jensen, A., Kalli, K.R., Karlan, B.Y., Kelemen, L.E., Kiemeney, L.A.L.M., Kjaer, S.K., Konecny, G.E., Krakstad, C., Kupryjanczyk, J., Lambrechts, D., Lambrechts, S., Le, N.D., Lee, N., Lee, J. van der, Leminen, A., Lim, B.K., Lissowska, J., Lubinski, J., Lundvall, L., Lurie, G., Massuger, L.F.A.G., and Altena, A.M. van

Abstract

Contains fulltext : 118459.pdf (publisher's version ) (Closed access), Genome-wide association studies (GWAS) have identified four susceptibility loci for epithelial ovarian cancer (EOC), with another two suggestive loci reaching near genome-wide significance. We pooled data from a GWAS conducted in North America with another GWAS from the UK. We selected the top 24,551 SNPs for inclusion on the iCOGS custom genotyping array. We performed follow-up genotyping in 18,174 individuals with EOC (cases) and 26,134 controls from 43 studies from the Ovarian Cancer Association Consortium. We validated the two loci at 3q25 and 17q21 that were previously found to have associations close to genome-wide significance and identified three loci newly associated with risk: two loci associated with all EOC subtypes at 8q21 (rs11782652, P = 5.5 x 10(-9)) and 10p12 (rs1243180, P = 1.8 x 10(-8)) and another locus specific to the serous subtype at 17q12 (rs757210, P = 8.1 x 10(-10)). An integrated molecular analysis of genes and regulatory regions at these loci provided evidence for functional mechanisms underlying susceptibility and implicated CHMP4C in the pathogenesis of ovarian cancer.

Published
2013

Catalog

Books, media, physical & digital resources
See catalog results